Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
3.04M
-
Shares change
-
+179K
-
Total reported value, excl. options
-
$929K
-
Value change
-
+$57.2K
-
Number of buys
-
11
-
Number of sells
-
-5
-
Price
-
$0.31
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2025
29 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2025.
IGC Pharma, Inc. - COM NEW (IGC) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.04M shares
.
Largest 10 shareholders include BlackRock, Inc. (704K shares), GEODE CAPITAL MANAGEMENT, LLC (703K shares), VANGUARD GROUP INC (645K shares), CITADEL ADVISORS LLC (271K shares), STATE STREET CORP (160K shares), NORTHERN TRUST CORP (113K shares), DEARBORN PARTNERS LLC (84.4K shares), GOLDMAN SACHS GROUP INC (65.5K shares), RENAISSANCE TECHNOLOGIES LLC (55K shares), and Virtu Financial LLC (46.9K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.